drugset / Trial / NCT03879889

Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong

NCT03879889 ↗

Phase 4 Completed 210 enrolled Chinese University of Hong Kong
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized controlled trial to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong.

Timeline

Start
2017-02-01
Primary completion
2019-07-31
Completion
2019-07-31

Outcome

Met primary endpoint

paper intervention group had significantly more biochemically validated ≥50% smoking reduction than the control: 27.1 vs. 10.0% (OR = 3.34, 95% CI: 1.16-9.62, P = 0.02). PMID 35498786 ↗

paper self-reported ≥50% smoking reduction was also significantly higher in the intervention group than the control: 51.9 vs. 20.2% (OR = 4.40, 95% CI: 2.38-8.12, P < 0.001). PMID 35498786 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown — —

Indications